SCHEMBL18274507

SCHEMBL18274507

COc1ccc(C(C#N)N2CCOCC2)cn1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 0.67
▸ ACHE P22303 5/20 0.61
▸ L3MBTL1 Q9Y468 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ RPS6KB1 P23443 1/20 0.52
▸ TSHR P16473 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ P2RX7 Q99572 1/20 0.41
▸ CD274 Q9NZQ7 1/20 0.37
▸ PRKDC P78527 1/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ OGA O60502 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18274496 0.82 ALDH1A1 (0.59) ALDH1A1ACHEL3MBTL1KDM4EHSD17B10
SCHEMBL7328074 0.80 ALDH1A1 (1.00) ALDH1A1ACHEL3MBTL1KDM4EHSD17B10
SCHEMBL15797521 0.80 ALDH1A1 (0.67) ALDH1A1ACHEL3MBTL1KDM4EHSD17B10
SCHEMBL9162336 0.78 ALDH1A1 (0.83) ALDH1A1ACHEL3MBTL1KDM4EHSD17B10
SCHEMBL12701471 0.77 ALDH1A1 (0.56) ALDH1A1ACHEL3MBTL1KDM4EHSD17B10
SCHEMBL18240274 0.76 ALDH1A1 (0.55) ALDH1A1ACHEL3MBTL1KDM4EHSD17B10
SCHEMBL15129303 0.76 RPS6KB1 (0.53) ALDH1A1L3MBTL1KDM4EHSD17B10SMN1; SMN2
SCHEMBL12701343 0.75 ALDH1A1 (0.54) ALDH1A1ACHEL3MBTL1KDM4EHSD17B10
SCHEMBL12701075 0.75 ALDH1A1 (0.53) ALDH1A1ACHEL3MBTL1KDM4EHSD17B10
SCHEMBL12701334 0.75 ALDH1A1 (0.58) ALDH1A1ACHEL3MBTL1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2931717-B1 INDOLE CARBOXAMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2016-12-07 — — EP disclosed
Send feedback